샘플 요청 목록

 카트 문의
시장보고서
상품코드
1564877

세계의 수술용 지혈제, 내부 조직 실란트 및 유착 방지제 시장

Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

외과용 지혈제, 내부 조직 실란트 및 접착 장벽 세계 시장은 2030년까지 78억 달러에 달할 것으로 예상

2023년 50억 달러로 추정되는 수술용 지혈제, 내부 조직 실란트 및 접착 장벽 세계 시장은 2023-2030년의 분석 기간 동안 연평균 6.7% 성장하여 2030년에는 78억 달러에 이를 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 지혈제는 CAGR 7.4%를 기록하여 분석 기간 종료 시점에 36억 달러에 도달할 것으로 예상됩니다. 내부 조직 밀봉제 부문의 성장률은 분석 기간 동안 CAGR 6.4%로 추정됩니다.

미국 시장은 13억 달러로 추정, 중국은 CAGR 11.1%로 성장 전망

미국의 수술용 지혈제, 내부 조직 실란트 및 접착 장벽 시장은 2023년 13억 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 19억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 11.1%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.8%와 6.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.5%의 성장률을 보일 것으로 예상됩니다.

세계 외과용 지혈제, 내부 조직 실란트 및 유착 방지제 시장 - 주요 동향 및 촉진요인 요약

수술용 지혈재, 체내 조직 봉합재, 접착 장벽은 왜 현대 수술에서 중요한가?

외과용 지혈제, 조직 내 봉합제, 유착 방지 장벽은 출혈을 억제하고 조직을 봉합하며 수술 후 유착을 방지하기 위해 수술에 사용되는 중요한 도구입니다. 이 제품들은 심혈관 수술, 정형외과, 신경외과 등 정확성과 안전성이 가장 중요한 복잡한 수술에 널리 사용되고 있습니다. 지혈제는 외과 의사가 출혈을 신속하게 제어하고 수혈의 필요성을 줄이고 환자의 결과를 개선하는 데 도움이 됩니다. 내부 조직 실란트는 상처와 절개 부위를 보다 효율적으로 봉합하는 데 도움이 되며, 접착 장벽은 합병증을 유발하는 내부 흉터 조직의 형성을 방지합니다. 외과 수술이 더욱 정교하고 전문화됨에 따라 이러한 제품에 대한 수요가 크게 증가하고 있습니다.

지혈제 및 조직 실란트 시장을 변화시키는 혁신이란?

외과용 지혈제 및 조직 실란트 시장은 급속한 기술 혁신을 겪고 있습니다. 응고 시간을 단축하고 부작용을 줄인 첨단 지혈제가 개발되어 수술 중 출혈을 더 잘 제어할 수 있게 되었습니다. 생체 흡수성 및 생분해성 실란트는 이물질을 체외로 제거하기 위한 추가 개입의 필요성을 줄여주기 때문에 인기를 끌고 있습니다. 합성 및 생물학적 조직 실란트의 기술 혁신은 생체 적합성을 향상시키고 강력한 접착력을 제공하여 고위험 수술에 이상적입니다. 또한, 최소침습 수술에 대한 관심이 높아지면서 복강경 및 로봇 수술에 적용할 수 있는 특수 실란트 및 접착 장벽이 개발되어 정확성과 환자 안전성을 향상시키고 있습니다.

외과용 지혈제 및 조직 실란트 산업을 주도하는 시장 세분화는?

제품 유형에는 국소 지혈제, 접착 실란트, 합성 접착 장벽이 있으며, 국소 지혈제는 일반 외과 수술에 널리 사용되어 가장 큰 시장 점유율을 차지합니다. 용도별로는 심혈관 수술, 정형외과, 신경외과가 주요 부문입니다. 이러한 수술은 출혈과 조직 유착을 정확하게 제어해야 하기 때문입니다. 병원이 주요 최종 사용자이지만, 최소 침습 수술이 보편화됨에 따라 외래수술센터(ASC)가 빠르게 이 제품을 채택하고 있습니다. 지역별로는 북미가 가장 큰 시장 점유율을 차지하고 유럽이 그 뒤를 잇고 있으며, 아시아태평양은 의료 투자 증가로 인해 빠르게 성장하고 있습니다.

외과용 지혈제, 조직 실란트 및 유착 방지제 시장의 성장을 가속하는 요인은 무엇인가?

외과용 지혈제, 조직 내 봉합재 및 유착 방지제 시장의 성장은 전 세계 수술 건수 증가, 최소침습 수술에 대한 수요 증가, 수술용 제품의 기술 발전 등 여러 요인에 의해 주도되고 있습니다. 심혈관 질환 및 정형외과 질환과 같은 만성 질환의 유행이 이러한 솔루션에 대한 수요를 촉진하고 있습니다. 또한, 유착과 같은 수술 후 합병증 감소에 대한 관심이 높아지면서 첨단 조직 실란트 및 유착 방지 장벽의 채택이 증가하고 있습니다. 신흥 경제국의 의료 인프라 확대와 신제품 연구개발에 대한 투자 증가는 시장 성장을 더욱 촉진하고 있습니다.

조사 대상 기업 예시(주목받는 44개사)

  • Axio Biosolutions Private Limited
  • Beacon Senior Advisors
  • Chitogen, Inc.
  • Corlison Pte.
  • Ethicon US LLC
  • GELITA MEDICAL
  • LifeBond Ltd.
  • Tissuemed Ltd.

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 스페인
    • 러시아
    • 기타 유럽
    • 아시아태평양
    • 호주
    • 인도
    • 한국
    • 기타 아시아태평양
    • 라틴아메리카
    • 아르헨티나
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
    • 중동
    • 이란
    • 이스라엘
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동
    • 아프리카

    제4장 경쟁

    LSH 24.10.07

    Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach US$7.8 Billion by 2030

    The global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$5.0 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Hemostats, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Internal Tissue Sealants segment is estimated at 6.4% CAGR over the analysis period.

    The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 11.1% CAGR

    The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

    Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market - Key Trends and Drivers Summarized

    Why Are Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Critical in Modern Surgery?

    Surgical hemostats, internal tissue sealants, and adhesion barriers are crucial tools used in surgeries to control bleeding, seal tissues, and prevent postoperative adhesions. These products are widely utilized in complex surgeries such as cardiovascular, orthopedic, and neurosurgical procedures, where precision and safety are paramount. Hemostats help surgeons control bleeding rapidly, reducing the need for blood transfusions and improving patient outcomes. Internal tissue sealants aid in closing wounds or incisions more efficiently, while adhesion barriers prevent the formation of internal scar tissue, which can lead to complications. As surgical procedures become more advanced and specialized, the demand for these products has significantly increased.

    What Innovations Are Transforming the Hemostats and Tissue Sealants Market?

    The market for surgical hemostats and tissue sealants is experiencing rapid innovation. Advanced hemostats with faster coagulation times and reduced side effects are being developed, offering better control over bleeding during surgeries. Bioabsorbable and biodegradable sealants are gaining traction as they reduce the need for additional interventions to remove foreign materials from the body. Innovations in synthetic and biologic tissue sealants provide enhanced biocompatibility and stronger adhesion, making them ideal for high-risk surgeries. Furthermore, the growing focus on minimally invasive surgeries has led to the development of specialized sealants and adhesion barriers that can be applied via laparoscopic or robotic techniques, offering enhanced precision and patient safety.

    Which Market Segments Are Leading in the Surgical Hemostats and Tissue Sealants Industry?

    Product types include topical hemostats, adhesive sealants, and synthetic adhesion barriers, with topical hemostats holding the largest market share due to their widespread use in general surgeries. In terms of application, cardiovascular, orthopedic, and neurosurgery are the leading segments, as these procedures require precise control over bleeding and tissue adhesion. Hospitals dominate as the primary end-users, although ambulatory surgery centers are rapidly adopting these products as minimally invasive surgeries become more common. Geographically, North America holds the largest market share, followed by Europe, while the Asia-Pacific region is witnessing rapid growth due to increasing healthcare investments.

    What Drives Growth in the Surgical Hemostats, Tissue Sealants, and Adhesion Barriers Market?

    The growth in the surgical hemostats, internal tissue sealants, and adhesion barriers market is driven by several factors, including the rising number of surgeries worldwide, increasing demand for minimally invasive procedures, and technological advancements in surgical products. The prevalence of chronic diseases such as cardiovascular and orthopedic conditions is fueling the demand for these solutions. Additionally, the growing focus on reducing postoperative complications, such as adhesions, is propelling the adoption of advanced tissue sealants and adhesion barriers. The expansion of healthcare infrastructure in emerging economies, along with increasing investments in research and development for new products, is further contributing to market growth.

    Select Competitors (Total 44 Featured) -

    • Axio Biosolutions Private Limited
    • Beacon Senior Advisors
    • Chitogen, Inc.
    • Corlison Pte. Limited
    • Ethicon US LLC
    • GELITA MEDICAL
    • LifeBond Ltd.
    • Tissuemed Ltd.

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • World Market Trajectories
      • Global Economic Update
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers - Global Key Competitors Percentage Market Share in 2024 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Rising Prevalence of Chronic Conditions Drives Growth in Hemostats and Tissue Sealants Market
      • Increasing Number of Surgical Procedures Spurs Demand for Advanced Hemostatic Products
      • Technological Advancements in Hemostats and Tissue Sealants Propel Market Expansion
      • Surge in Trauma and Emergency Care Procedures Expands Market Potential for Hemostatic Solutions
      • Growing Preference for Minimally Invasive Procedures Drives Adoption of Adhesion Barriers
      • Surge in Cardiovascular and Neurological Surgeries Boosts Demand for Internal Tissue Sealants
      • Focus on Reducing Surgical Complications Propels Adoption of Next-Generation Hemostats
      • Development of Biodegradable and Bioabsorbable Hemostats Expands Product Innovations
      • Rising Incidence of Cancer Surgeries Generates Demand for Internal Tissue Sealants
      • Growth of Cosmetic and Reconstructive Surgeries Throws Spotlight on Adhesion Barriers
      • Expansion of Outpatient Surgery Centers Drives Demand for Easy-to-Use Hemostats and Sealants
      • Focus on Personalized and Precision Medicine Spurs Development of Tailored Hemostatic Products
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
      • TABLE 2: World Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 3: World Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 4: World 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
      • TABLE 5: World Recent Past, Current & Future Analysis for Hemostats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 6: World Historic Review for Hemostats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 7: World 16-Year Perspective for Hemostats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 8: World Recent Past, Current & Future Analysis for Internal Tissue Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 9: World Historic Review for Internal Tissue Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 10: World 16-Year Perspective for Internal Tissue Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 11: World Recent Past, Current & Future Analysis for Adhesion Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 12: World Historic Review for Adhesion Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 13: World 16-Year Perspective for Adhesion Barriers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 14: World Recent Past, Current & Future Analysis for Surgical Repair Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 15: World Historic Review for Surgical Repair Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 16: World 16-Year Perspective for Surgical Repair Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 17: World Recent Past, Current & Future Analysis for Trauma Cases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 18: World Historic Review for Trauma Cases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 19: World 16-Year Perspective for Trauma Cases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 27: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 28: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 29: USA Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 30: USA Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 31: USA 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 32: USA Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 33: USA Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 34: USA 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 35: USA Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 36: USA Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 37: USA 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • CANADA
      • TABLE 38: Canada Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 39: Canada Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 40: Canada 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 41: Canada Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 42: Canada Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 43: Canada 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 44: Canada Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 45: Canada Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 46: Canada 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • JAPAN
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 47: Japan Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 48: Japan Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 49: Japan 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 50: Japan Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 51: Japan Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 52: Japan 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 53: Japan Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 54: Japan Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 55: Japan 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • CHINA
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 56: China Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 57: China Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 58: China 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 59: China Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 60: China Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 61: China 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 62: China Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 63: China Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 64: China 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • EUROPE
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 65: Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 66: Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 67: Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
      • TABLE 68: Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 69: Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 70: Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 71: Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 72: Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 73: Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 74: Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 75: Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 76: Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • FRANCE
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 77: France Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 78: France Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 79: France 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 80: France Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 81: France Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 82: France 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 83: France Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 84: France Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 85: France 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • GERMANY
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 86: Germany Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 87: Germany Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 88: Germany 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 89: Germany Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 90: Germany Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 91: Germany 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 92: Germany Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 93: Germany Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 94: Germany 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • ITALY
      • TABLE 95: Italy Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 96: Italy Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 97: Italy 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 98: Italy Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 99: Italy Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 100: Italy 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 101: Italy Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 102: Italy Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 103: Italy 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • UNITED KINGDOM
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 104: UK Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 105: UK Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 106: UK 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 107: UK Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 108: UK Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 109: UK 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 110: UK Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 111: UK Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 112: UK 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • SPAIN
      • TABLE 113: Spain Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 114: Spain Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 115: Spain 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 116: Spain Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 117: Spain Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 118: Spain 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 119: Spain Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 120: Spain Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 121: Spain 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • RUSSIA
      • TABLE 122: Russia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 123: Russia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 124: Russia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 125: Russia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 126: Russia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 127: Russia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 128: Russia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 129: Russia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 130: Russia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • REST OF EUROPE
      • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 132: Rest of Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 133: Rest of Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 135: Rest of Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 136: Rest of Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 138: Rest of Europe Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 139: Rest of Europe 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • ASIA-PACIFIC
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 141: Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 142: Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
      • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 144: Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 145: Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 147: Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 148: Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 150: Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 151: Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • AUSTRALIA
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
      • TABLE 152: Australia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 153: Australia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 154: Australia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 155: Australia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 156: Australia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 157: Australia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 158: Australia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 159: Australia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 160: Australia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • INDIA
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
      • TABLE 161: India Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 162: India Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 163: India 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 164: India Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 165: India Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 166: India 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 167: India Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 168: India Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 169: India 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • SOUTH KOREA
      • TABLE 170: South Korea Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 171: South Korea Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 172: South Korea 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 173: South Korea Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 174: South Korea Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 175: South Korea 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 176: South Korea Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 177: South Korea Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 178: South Korea 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • REST OF ASIA-PACIFIC
      • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 180: Rest of Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 183: Rest of Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 186: Rest of Asia-Pacific Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • LATIN AMERICA
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
      • TABLE 188: Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 189: Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 190: Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
      • TABLE 191: Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 192: Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 193: Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 194: Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 195: Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 196: Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 197: Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 198: Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 199: Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • ARGENTINA
      • TABLE 200: Argentina Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 201: Argentina Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 202: Argentina 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 203: Argentina Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 204: Argentina Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 205: Argentina 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 206: Argentina Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 207: Argentina Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 208: Argentina 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • BRAZIL
      • TABLE 209: Brazil Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 210: Brazil Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 211: Brazil 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 212: Brazil Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 213: Brazil Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 214: Brazil 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 215: Brazil Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 216: Brazil Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 217: Brazil 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • MEXICO
      • TABLE 218: Mexico Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 219: Mexico Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 220: Mexico 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 221: Mexico Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 222: Mexico Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 223: Mexico 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 224: Mexico Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 225: Mexico Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 226: Mexico 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • REST OF LATIN AMERICA
      • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 228: Rest of Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 229: Rest of Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 231: Rest of Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 232: Rest of Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 234: Rest of Latin America Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 235: Rest of Latin America 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • MIDDLE EAST
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
      • TABLE 236: Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
      • TABLE 237: Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 238: Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
      • TABLE 239: Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 240: Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 241: Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 242: Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 243: Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 244: Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 245: Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 246: Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 247: Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • IRAN
      • TABLE 248: Iran Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 249: Iran Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 250: Iran 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 251: Iran Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 252: Iran Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 253: Iran 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 254: Iran Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 255: Iran Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 256: Iran 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • ISRAEL
      • TABLE 257: Israel Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 258: Israel Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 259: Israel 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 260: Israel Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 261: Israel Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 262: Israel 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 263: Israel Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 264: Israel Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 265: Israel 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • SAUDI ARABIA
      • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 267: Saudi Arabia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 268: Saudi Arabia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 270: Saudi Arabia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 271: Saudi Arabia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 273: Saudi Arabia Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 274: Saudi Arabia 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • UNITED ARAB EMIRATES
      • TABLE 275: UAE Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 276: UAE Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 277: UAE 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 278: UAE Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 279: UAE Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 280: UAE 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 281: UAE Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 282: UAE Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 283: UAE 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • REST OF MIDDLE EAST
      • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 285: Rest of Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 286: Rest of Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 288: Rest of Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 289: Rest of Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 291: Rest of Middle East Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 292: Rest of Middle East 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030
    • AFRICA
      • Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
      • TABLE 293: Africa Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 294: Africa Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Hemostats, Internal Tissue Sealants and Adhesion Barriers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 295: Africa 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Product Type - Percentage Breakdown of Value Sales for Hemostats, Internal Tissue Sealants and Adhesion Barriers for the Years 2014, 2024 & 2030
      • TABLE 296: Africa Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 297: Africa Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Surgical Repair Applications and Trauma Cases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 298: Africa 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by Application - Percentage Breakdown of Value Sales for Surgical Repair Applications and Trauma Cases for the Years 2014, 2024 & 2030
      • TABLE 299: Africa Recent Past, Current & Future Analysis for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
      • TABLE 300: Africa Historic Review for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Hospitals, Ambulatory Surgery Centers and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
      • TABLE 301: Africa 16-Year Perspective for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Specialty Clinics for the Years 2014, 2024 & 2030

    IV. COMPETITION

    • 샘플 요청 목록
    0 건의 상품을 선택 중
    목록 보기
    전체삭제